Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Theratechnologies Revenue (Quarterly): 22.60M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 22.60M |
| May 31, 2024 | 22.02M |
| February 29, 2024 | 16.25M |
| November 30, 2023 | 23.45M |
| August 31, 2023 | 20.86M |
| May 31, 2023 | 17.55M |
| February 28, 2023 | 19.91M |
| November 30, 2022 | 21.42M |
| August 31, 2022 | 20.81M |
| May 31, 2022 | 19.27M |
| February 28, 2022 | 18.56M |
| November 30, 2021 | 18.75M |
| August 31, 2021 | 17.85M |
| May 31, 2021 | 17.79M |
| February 28, 2021 | 15.43M |
| November 30, 2020 | 19.12M |
| August 31, 2020 | 14.05M |
| May 31, 2020 | 17.16M |
| February 29, 2020 | 15.72M |
| November 30, 2019 | 16.40M |
| August 31, 2019 | 16.11M |
| May 31, 2019 | 15.61M |
| February 28, 2019 | 15.10M |
| November 30, 2018 | 13.98M |
| August 31, 2018 | 13.52M |
| Date | Value |
|---|---|
| May 31, 2018 | 9.598M |
| February 28, 2018 | 8.113M |
| November 30, 2017 | 9.330M |
| August 31, 2017 | 8.886M |
| May 31, 2017 | 7.435M |
| February 28, 2017 | 6.849M |
| November 30, 2016 | 7.200M |
| August 31, 2016 | 6.818M |
| May 31, 2016 | 6.921M |
| February 29, 2016 | 6.452M |
| November 30, 2015 | 6.586M |
| August 31, 2015 | 6.942M |
| May 31, 2015 | 5.858M |
| February 28, 2015 | 3.653M |
| November 30, 2014 | 2.135M |
| August 31, 2014 | 0.0037M |
| May 31, 2014 | 2.205M |
| February 28, 2014 | 1.503M |
| November 30, 2013 | 1.132M |
| August 31, 2013 | 2.065M |
| May 31, 2013 | 2.262M |
| February 28, 2013 | 1.757M |
| November 30, 2012 | 3.922M |
| August 31, 2012 | 3.849M |
| May 31, 2012 | 2.577M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
14.05M
Minimum
Aug 2020
23.45M
Maximum
Nov 2023
18.75M
Average
18.66M
Median
Revenue (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 67.77M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| InMed Pharmaceuticals Inc | 1.283M |
| Xenon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.091M |
| Total Expenses (Quarterly) | 16.39M |
| EPS Diluted (Quarterly) | 0.06 |
| Enterprise Value | 74.38M |
| Gross Profit Margin (Quarterly) | 80.00% |
| Profit Margin (Quarterly) | 13.68% |
| Earnings Yield | -4.13% |
| Operating Earnings Yield | 18.14% |
| Normalized Earnings Yield | -1.952 |